Making Sense of the Diagnosis: Criteria and Lab Reports
Last updated:
Rett syndrome is a clinical diagnosis based on the Neul criteria, which requires a period of regression and the loss of specific skills like hand use and language. Genetic testing for MECP2 mutations is then used to confirm the doctor's observations and identify the exact biological cause.
Key Takeaways
- • Rett syndrome is primarily diagnosed clinically by observing specific symptoms outlined in the Neul criteria.
- • A classic diagnosis requires a period of developmental regression followed by stability, plus the loss of hand skills, spoken language, and the onset of repetitive hand movements.
- • Genetic testing for mutations in the MECP2 gene is used to confirm the doctor's clinical diagnosis and identify the biological cause.
- • Genetic lab reports classify mutations as pathogenic (disease-causing), likely pathogenic, or a Variant of Uncertain Significance (VUS).
- • Although symptoms vary, certain 'hot-spot' MECP2 mutations are generally associated with either milder or more severe clinical progressions.
Decoding a medical diagnosis often starts with two things: a clinical exam and a genetic lab report. In Rett syndrome, the diagnosis is primarily clinical, meaning it is based on the symptoms a doctor sees [1]. Genetic testing is used to confirm what the doctor observes and to provide deeper insight into the specific biological cause [2].
The Clinical “Gold Standard”: Neul Criteria
To receive a definitive diagnosis of Classic Rett syndrome, a child must meet the “Neul criteria.” This requires a period of regression (loss of skills) followed by a period of stability, plus four specific “Main Criteria” [3][4]:
- Loss of purposeful hand skills: Losing the ability to pick up items, point, or reach.
- Loss of spoken language: Losing words or babbling that was previously present.
- Gait abnormalities: Developing an unsteady, wide-based walk or losing the ability to walk entirely.
- Hand stereotypies: The emergence of repetitive movements like wringing, squeezing, clapping, or tapping.
If a child has some but not all of these, they may be diagnosed with Atypical Rett syndrome, which requires meeting at least two of the main criteria plus five “Supportive Criteria” (such as breathing issues, teeth grinding, or small, cold hands) [5][3].
Reading the Genetic Lab Report
The lab report can feel like a foreign language. Here are the most important terms you will see:
- Pathogenic / Likely Pathogenic: These terms mean the lab is very confident that this specific genetic change is causing the symptoms [6].
- VUS (Variant of Uncertain Significance): This means a change was found, but there isn’t enough scientific data yet to know if it causes Rett syndrome or if it’s just a normal human variation [7].
- De Novo: This means the mutation is “new” in the child and was not inherited from either parent [8].
- Mutation Types:
- Missense: One “letter” of the DNA code is swapped for another. Some, like R133C, are often associated with milder symptoms [9][10].
- Nonsense / Truncating: The DNA code is cut short, like a sentence ending in the middle. These often lead to a more complete loss of the MECP2 protein [11][6].
- Frameshift: A “letter” is added or deleted, which shifts the entire DNA sequence and scrambles the instructions [11].
Common “Hot-Spot” Mutations
About 60-70% of MECP2 mutations occur at specific “hot-spots” on the gene [12]. While a mutation does not perfectly predict a child’s future, certain patterns have emerged in research [13]:
- Generally milder: R133C, R294X, and R306C [9].
- Generally more severe: R106W, R168X, and R255X [9].
- T158M: This is the most common mutation and can vary significantly in its presentation [9].
Completeness Checklist for Diagnosis
For a diagnosis to be considered definitive, your medical team should have documented the following:
- [ ] Clinical History: Evidence of a period of typical development followed by regression [14].
- [ ] Main Criteria Assessment: Documentation of hand skills, language, gait, and stereotypies [3].
- [ ] Exclusion Check: Confirmation that the symptoms aren’t better explained by a brain injury or metabolic disorder [4].
- [ ] Genetic Confirmation: A lab report identifying a pathogenic variant in MECP2 [1]. Note: You can still have a diagnosis without a mutation if clinical criteria are met [15].
Frequently Asked Questions
How is Rett syndrome definitively diagnosed?
Can a child have Rett syndrome without an MECP2 mutation?
What does VUS mean on a genetic lab report?
What is Atypical Rett syndrome?
Do specific MECP2 mutations predict how severe Rett syndrome will be?
Questions for Your Doctor
- • Which specific 'hot-spot' mutation does my child have, and what does the current research say about its typical clinical progression?
- • If my child's result is a VUS (Variant of Uncertain Significance), what is the plan for re-evaluating this result as more data becomes available?
- • Does my child currently meet all four 'Main Criteria' for a classic Rett syndrome diagnosis?
- • How do my child's supportive symptoms, like breathing irregularities or sleep issues, factor into their specific diagnosis?
- • Can you walk me through the 'Notes' or 'Interpretation' section of the lab report to explain why this specific variant was classified as pathogenic?
Questions for You
- • What specific terms on the genetic report are most confusing to you right now? Writing them down can help you get clear answers.
- • Has your child experienced a clear period of regression (loss of skills), or have their challenges been present since birth? This is a key detail for the diagnostic criteria.
- • Do you have a copy of the full laboratory report? Having the physical or digital document is essential for future specialist consultations.
- • Which of the 'Supportive Criteria' (like cold hands, teeth grinding, or breathing issues) have you observed in your child? Tracking these can help your doctor.
Want personalized information?
Type your question below to get evidence-based answers tailored to your situation.
References
- 1
Clinical and functional outcomes in pediatric patients with Rett syndrome: a 15-year retrospective study.
Ferreira MC, De Beir J, Barreto MI, et al.
European journal of pediatrics 2025; (184(7)):465 doi:10.1007/s00431-025-06291-6.
PMID: 40608138 - 2
[Features of premorbid status in patients with Rett syndrome].
Fedoseeva IF, Goncharenko VA, Goncharenko AV, et al.
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 2026; (126(2)):136-143 doi:10.17116/jnevro2026126021136.
PMID: 41782542 - 3
Rett-like Phenotypes in HNRNPH2-Related Neurodevelopmental Disorder.
Gonzalez JN, Goldman S, Carter MT, Bain JM
Genes 2023; (14(6)) doi:10.3390/genes14061154.
PMID: 37372334 - 4
Rett Syndrome Spectrum in Monogenic Developmental-Epileptic Encephalopathies and Epilepsies: A Review.
Spagnoli C, Fusco C, Pisani F
Genes 2021; (12(8)) doi:10.3390/genes12081157.
PMID: 34440332 - 5
An Atypical Rett Syndrome Phenotype Due to a Novel Missense Mutation in CACNA1A.
Epperson MV, Haws ME, Standridge SM, Gilbert DL
Journal of child neurology 2018; (33(4)):286-289 doi:10.1177/0883073818754987.
PMID: 29366381 - 6
Novel Mutations of the TYMP Gene in Mitochondrial Neurogastrointestinal Encephalomyopathy: Case Series and Literature Review.
Mojtabavi H, Fatehi F, Shahkarami S, et al.
Journal of molecular neuroscience : MN 2021; (71(12)):2526-2533 doi:10.1007/s12031-021-01822-w.
PMID: 33825174 - 7
Clinical Utility of Reinterpreting Previously Reported Genomic Epilepsy Test Results for Pediatric Patients.
SoRelle JA, Thodeson DM, Arnold S, et al.
JAMA pediatrics 2019; (173(1)):e182302 doi:10.1001/jamapediatrics.2018.2302.
PMID: 30398534 - 8
Identification of a New Variant of PUF60 Gene: Case Presentation and Literature Review.
Toader DO, Ursu R, Bacalbasa N, et al.
Cancer diagnosis & prognosis 2021; (1(3)):213-219 doi:10.21873/cdp.10029.
PMID: 35399315 - 9
MECP2 mutation spectrum and its clinical characteristics in a Chinese cohort.
Wen Y, Wang J, Zhang Q, et al.
Clinical genetics 2020; (98(3)):240-250 doi:10.1111/cge.13790.
PMID: 32472557 - 10
Rett Syndrome and MECP2 Duplication Syndrome: Disorders of MeCP2 Dosage.
Collins BE, Neul JL
Neuropsychiatric disease and treatment 2022; (18()):2813-2835 doi:10.2147/NDT.S371483.
PMID: 36471747 - 11
A novel frameshift CUX2 variant in a patient with epilepsy and global developmental delay: Phenotypic and genotypic expansion.
Romano F, Shams Nosrati MS, Madia F, et al.
European journal of medical genetics 2026; (79()):105064 doi:10.1016/j.ejmg.2025.105064.
PMID: 41344425 - 12
A RETT SYNDROME CASE WITH NOVEL NON-IDENTICAL MUTATION IN MECP2 GENE.
Güngör O, Kirik S, Cevizli D, et al.
Genetic counseling (Geneva, Switzerland) 2015; (26(4)):387-92.
PMID: 26852508 - 13
MECP2 mutations in Czech patients with Rett syndrome and Rett-like phenotypes: novel mutations, genotype-phenotype correlations and validation of high-resolution melting analysis for mutation scanning.
Zahorakova D, Lelkova P, Gregor V, et al.
Journal of human genetics 2016; (61(7)):617-25 doi:10.1038/jhg.2016.19.
PMID: 26984561 - 14
Clinical Feature and Genetics in Rett Syndrome: A Report on Iranian Patients.
Karimzadeh P, Kheirollahi M, Houshmand SM, et al.
Iranian journal of child neurology 2019; (13(4)):37-51.
PMID: 31645865 - 15
Genetic and clinical variations in a Norwegian sample diagnosed with Rett syndrome.
Henriksen MW, Breck H, Sejersted Y, et al.
Brain & development 2020; (42(7)):484-495 doi:10.1016/j.braindev.2020.03.008.
PMID: 32336485
This page is for educational purposes only and should not replace professional medical advice. Always consult your pediatric neurologist or genetic counselor to interpret your child's specific clinical symptoms and genetic lab results.
Stay up to date
Get notified when new research about Rett syndrome is published.
No spam. Unsubscribe anytime.